{
  "compound": "CBD for arthritis",
  "condition": "ARTHRITIS",
  "effect_size": "N/A (guideline)",
  "study_type": "CLINICAL_GUIDELINE",
  "source": "NORML:ARTHRITIS_GUIDELINE_001",
  "participants": "Guidelines based on systematic review and international expert consensus (42 rheumatologists)",
  "year": 2021,
  "notes": "Clinical Practice Guidelines for Cannabinoid Use in Arthritis: ACR/EULAR Consensus",
  "confidence": "medium",
  "abstract": "Conditional recommendation (Grade B) for CBD in RA/OA when NSAIDs inadequate or contraindicated; Strong recommendation (Grade A) for topical CBD in localized OA"
}